Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
about
Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies.NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract.Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.[Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell].
P2860
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
@en
type
label
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
@en
prefLabel
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
@en
P2093
P2860
P356
P1476
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
@en
P2093
Eiji Kashiwagi
George J Netto
Hiroshi Miyamoto
Hitoshi Ishiguro
Takashi Kawahara
Yichun Zheng
Yurina Miyamoto
P2860
P304
P356
10.1002/MC.22265
P577
2015-01-15T00:00:00Z